M&A Deal Summary |
|
---|---|
Date | 2021-04-01 |
Target | MYM |
Sector | Medical Products |
Buyer(s) | IM Cannabis |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2008 |
Sector | Consumer Products |
Employees | 95 |
Revenue | 49M CAD (2023) |
IM Cannabis is an international cannabis company providing premium products to medical patients and adult-use recreational consumers. The ecosystem created through its international operations leverages the Company's unique data-driven perspective and product supply chain globally. With its commitment to responsible growth and financial prudence, and the ability to operate within the strictest regulatory environments, the Company has quickly become one of the leading cultivators and distributors of high-quality cannabis globally. IM Cannabis was incorporated in 2008 and is based in Tel Aviv, Israel.
DEAL STATS | # |
---|---|
Overall | 1 of 2 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 2 |
State (British Columbia) | 1 of 1 |
Country (Canada) | 1 of 1 |
Year (2021) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-03-30 |
Oranim Pharm
Jerusalem, Israel Oranim Pharm is a pharmacy selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area. |
Buy | - |